<DOC>
	<DOCNO>NCT00841724</DOCNO>
	<brief_summary>The goal prospective study ass overall mortality ( whether relate relapse/progression toxicity - TRM- ) one year allogeneic stem cell transplantation prepare so-called reduced-toxicity `` submyeloablative '' condition regimen patient hematological malignancy .</brief_summary>
	<brief_title>Study Reduced-toxicity `` Submyeloablative '' Conditioning Regimen Prior Allogeneic Stem Cell Transplantation Patients With Hematological Malignancies</brief_title>
	<detailed_description />
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Fludarabine</mesh_term>
	<mesh_term>Busulfan</mesh_term>
	<criteria>Patients affiliate social security reimbursement system Adults ( men woman ) age 18 65 year Negative test pregnancy ECOG 01 Karnofsky Index â‰¥ 70 % Availability HLAidentical sibling donor , HLAmatched unrelated donor ( 10/10 HLA compatibility A , B , C , DRB1 , DQB1 ( single allelic mismatch level Cw accept ) Life expectancy &gt; 6 month Signed informed consent Diagnosis hematological malignancy consider eligible allogeneic stem cell transplantation Pregnant woman willing take effective contraception Classical contraindication allogeneic stem cell transplantation procedure Any contraindication use drug contain within condition regimen accord summary product characteristic Patients age &lt; 50 year deem eligible `` standard '' conventional myeloablative conditioning regimen An HLAmatched sibling donor contraindication stem cell mobilization collection History uncontrolled psychiatric condition Patients participate another trial test experimental drug within one month prior inclusion protocol .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>May 2012</verification_date>
	<keyword>Allogeneic stem cell transplantation</keyword>
	<keyword>Reduced-intensity conditioning</keyword>
	<keyword>Reduced-toxicity conditioning</keyword>
	<keyword>Hematological malignancy</keyword>
	<keyword>IV Busulfan</keyword>
</DOC>